Fmoc-DmbGly-OH

Nom chimique: N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-(2,4-dimethoxybenzyl)-glycine // Synonymes: Fmoc-N-(2,4-dimethoxybenzyl)-glycine, N-(9-Fluorenylmethyloxycarbonyl)-N-(2,4-dimethoxybenzyl)-2-aminoacetic acid

  • n° Art.:FAA3390
  • n° CAS:166881-42-1
  • Formule:C26H25NO6
  • Storage temperature:2-8°C
  • Masse moléculaire:447,48 g/mol

from 95,00 €

Grouped product items
Nombre Unité de vente Prix SKU Disponibilité
1 g
95,00 €
FAA3390.0001
<10 jour ouvrables
5 g
450,00 €
FAA3390.0005
<10 jour ouvrables
25 g
1 800,00 €
FAA3390.0025
<10 jour ouvrables
Fiches de données de sécurité
description

Dmb and Tmb can be used for temporary protection of the amide nitrogen of a peptide bond. Furthermore Dmb and Tmb amino acids prevent aggregation during solid phase synthesis and can prevent aspartimide formation when it is introduced before an Asp residue. They can also increase peptide cyclization efficiency. Standard coupling protocols can be applied

with reagents such as PyBOP, DIC/HOBt or HATU. Acidic deprotection methods used with Wang resin generate the native sequence.

references

N,O-bisFmoc derivatives of N-(2-hydroxy-4-methoxybenzyl)-amino acids: Useful intermediates in peptide synthesis; T. Johnson, M. Quibell, R. C. Sheppard; J. Pept. Sci. 1995; 1(1): 11-25. https://doi.org/10.1002/psc.310010104.


Innovation and perspectives in solid phase synthesis: peptides, proteins and nucleic acids, biological and biomedical applications; J. F. Kennedy, C. J. Knill; edited by R. Epton; Mayflower Scientific Ltd 1995; 71. https://doi.org/10.1002/pi.1995.210380416.


Proceeding of the 24th EPS; K. Jauch et al; edited by R. Ramage, R. Epton; Mayflower Scientific Ltd 1996; 497.


All-L-Leu-Pro-Leu-Pro: a challenging cyclization; M. El Haddadi, F. Cavelier, E. Vives, A. Azmani, J. Verducci, J. Martinez; J. Pept. Sci. 2000; 6(11): 560-570. https://doi.org/10.1002/1099-1387(200011)6:11<560::AID-PSC275>3.0.CO;2-I.


Efficient synthesis and comparative studies of the arginine and Nomega,Nomega-dimethylarginine forms of the human nucleolin glycine/arginine rich domain; S. Zahariev, C. Guarnaccia, F. Zanutin, A. Pintar, G. Esposito, G. Marviæ, B. Krust, A. G. Hovanessian, S. Pongor; J. Pept. Sci. 2005; 11(1): 17-28. https://doi.org/10.1002/psc.577.


Besoin d'informations supplémentaires sur ce produit?

entrer en contact

Contact rapide

Veuillez m'envoyer plus d'informations sur

Des produits qui pourraient également vous intéresser!